首页> 外文会议>Conference on Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems >Multispectral fluorescence imaging of human ovarian and Fallopian tube tissue for early stage cancer detection
【24h】

Multispectral fluorescence imaging of human ovarian and Fallopian tube tissue for early stage cancer detection

机译:人卵巢和输卵管组织早期癌症检测的多光谱荧光成像

获取原文

摘要

With early detection, five year survival rates for ovarian cancer are over 90%, yet no effective early screening method exists. Emerging consensus suggests that perhaps over 50% of the most lethal form of the disease, high grade serous ovarian cancer, originates in the Fallopian tube. Cancer changes molecular concentrations of various endogenous fluorophores. Using specific excitation wavelengths and emissions bands on a Multispectral Fluorescence Imaging (MFI) system, spatial and spectral data over a wide field of view can be collected from endogenous fluorophores. Wavelength specific reflectance images provide additional information to normalize for tissue geometry and blood absorption. Ratiometric combination of the images may create high contrast between neighboring normal and abnormal tissue. Twenty-six women undergoing oophorectomy or debulking surgery consented the use of surgical discard tissue samples for MFI imaging. Forty-nine pieces of ovarian tissue and thirty-two pieces of Fallopian tube tissue were collected and imaged with excitation wavelengths between 280 nm and 550 nm. After imaging, each tissue sample was fixed, sectioned and H&E stained for pathological evaluation. Comparison of mean intensity values between normal, benign, and cancerous tissue demonstrate a general trend of increased fluorescence of benign tissue and decreased fluorescence of cancerous tissue when compared to normal tissue. The predictive capabilities of the mean intensity measurements are tested using multinomial logistic regression and quadratic discriminant analysis. Adaption of the system for in vivo Fallopian tube and ovary endoscopic imaging is possible and is briefly described.
机译:早期检测,卵巢癌的五年存活率超过90%,但没有有效的早期筛查方法存在。新兴共识表明,患有最致命的疾病形式的50%以上,患有高级浆膜癌癌症,来自输卵管。癌症改变各种内源荧光团的分子浓度。在多光谱荧光成像(MFI)系统上使用特定的激发波长和发射带,可以从内源荧光团收集宽视野上的空间和光谱数据。波长特定的反射率图像提供了用于组织几何形状和吸血力的额外信息。图像的比例组合可以在相邻的正常和异常组织之间产生高对比度。经历奥菲思切术或剥夺手术的二十六名女性同意使用外科丢弃组织样品进行MFI成像。收集49件卵巢组织和三十二片输卵管组织,并在280nm和550nm之间的激发波长上成像。在成像后,将每个组织样品固定,切片和H&E染色以进行病理评估。与正常组织相比,正常,良性和癌组织之间平均强度值的比较表明了良性组织荧光增加的一般趋势,并减少了癌组织的荧光。使用多项逻辑回归和二次判别分析测试平均强度测量的预测能力。用于体内输卵管和卵巢内窥镜成像系统的适应是可能的,是简要描述。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号